https://www.selleckchem.com/products/alc-0159.html
In their new article in the Journal of Investigative Dermatology, Tseng et al. (2021) confirm that the sensitivity of melanoma cells to anti‒PD-L1 checkpoint inhibitor therapy is correlated with high PD-L1 surface expression. By blocking PD-L1 membrane clearing, controlled by LRP1 and PAI-1, the expression of high-cell-surface levels of PD-L1 was maintained.Although several anticytokine antibodies and inhibitors are available for the treatment of psoriasis, more effective or better-tolerated alternatives would be of interest. In their
Like
Comment
Share
